Video
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how specialty pharmacists can show their value during the NASP Annual Meeting in Washington, DC.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how specialty pharmacists can show their value during the NASP Annual Meeting in Washington, DC.
JO: Specialty pharmacies are really in the perfect position to capture data that can drive some of the outcomes that are being looked for by all of the constituents in the marketplace. You figure that specialty pharmacies are the ones that have a more frequent touch point with the patients, more frequent touchpoint with the physicians. So, they have the opportunity to capture these items and these elements that can really drive consistency across the marketplace.
And that’s where specialties are really beneficial to help to capture, but to my point earlier. Unless you have the data standardization to know what you’re capturing, it makes it very difficult from pharmacy A and pharmacy B to marry those outcomes types of elements and make it usable types of data.
FDA Grants Orphan Drug Designation to MDL-101 for Congenital Muscular Dystrophy Type 1a